Herpes ZOSTER - CLASS NOTES Flashcards

1
Q

Where does herpes zoster virus lay dormant after primary varicella infection?

A

Sensory nerve ganglia

After chickenpox, VZV migrates to these sensory nerve ganglia and establishes lifelong latency. VZV reactivation typically occurs in elderly people, however it can be predisposed in younger adults due to weakened immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What causes reactivation of herpes zoster?

A

Reactivation can be triggered by:

Advanced age
Trauma
Stress
Immunosuppression

Transmission of infection can occur by direct contact with skin lesions or airborne route if there is presence of disseminated herpes zoster.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe how varicella turns to herpes zoster?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the clinical presentation of herpes zoster?

A

Herpes zoster is characterized by a painful, unilateral vesicular eruption, which usually occurs in a single or two contiguous, dermatomes

Prodromal symptoms (1-5 days before rash appears) may include malaise, headaches, fatigue or fever. Pain, itching, tingling in the area where rash will develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the Shingles rash?

A

Involves 1 – 2 adjacent dermatomes on one side of the body, generally not crossing the body’s midline.
The rash forms blisters that typically scab over in 7 – 10 days and clears up within 2 – 4 weeks. The rash can be hemorrhagic in immunosuppressed people and people of advanced age.
In rare cases, the rash may be more widespread or affect the eye
Prodromal systemic symptoms as mentioned above may continue throughout the infection.
Scarring and hypo- or hyperpigmentation may persist months to years after herpes zoster has resolved. The development of new lesions more than a week after presentation should raise concerns regarding possible underlying immunodeficiency.
Although the rash can occur in any dermatome, the thoracic and lumbar dermatomes are most commonly involved.
The most common complication of shingles is postherpetic neuralgia (PHN), a nerve pain that persists after the rash has resolved and can last from weeks to years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some non-pharm management strategies for shingles?

A
  • Keep rash clean and dry to reduce risk of bacterial superinfection
  • Prevent transmission of the virus
  • Keep fluid-filled blisters and rash covered
  • Wash hands often
  • Do not touch or scratch the rash
  • Avoid use of topical antibiotics and dressing with adhesives
  • May cause irritation and delay rash healing
  • Use sterile wet dressings to relieve discomfort in some patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When should antivirals be initiated after rash onset for shingles?

A

Initiated within 72 hours of rash onset, reduces duration of viral shedding, acute pain and the appearance of new lesions. After 72 hours, efficacy of anti-virals is NOT well-established hence pain managment remains the mainstay of therapy unless there is ocular involvement.
Treat ocular zoster even if rash has been present for up to 7 days
Refer for ophthalmological assessment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What drugs should be used to treat shingles rash?

A

Acyclovir 800mg 5X daily for 7 days
Valacyclovir 1000mg TID for 7 days
Famciclovir 500mg TID for 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the three types of neuralgias that can occur with Shingles rash?

A
  1. Acute pain (within 30 days)
  2. Subacute pain (between 30 days and 90 to 120 days of rash onset)
  3. Postherpetic neuralgia (beyond 120 days of rash onset)

Approximately 10 to 15 percent of patients with herpes zoster will develop postherpetic neuralgia. Individuals older than 60 years of age account for 50 percent of these cases. Immunosuppressed patients also have a higher incidence.
Vaccinated adults are less likely to develop postherpetic neuralgia, even if HZ infection occurs.
Significant pain is considered a pain level 3 or higher on a pain scale of 1 to 10.
Sensory symptoms can also include numbness, dysesthesias, pruritus, and allodynia in the affected dermatome
Antiviral treatment does not reduce risk of postherpetic neuralgia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What % of patients with herpes zoster develop post herpetic neuralgia?

A

About 10 to 15 percent of patients with herpes zoster will develop postherpetic neuralgia

Individuals older than 60 years of age account for 50 percent of these cases. Immunosuppressed patients also have a higher incidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Does vaccination reduce the chance of developing poster herpetic neuralgia?

A

YES! Evenif HZ infection occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is considered significant pain regarding shingles pain?

A

Pain level of 3 or higher on a pain scale of 1 to 10.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What type of symptoms occur with neuralgia?

A

Sensory symptoms can include numbness, dysesthesias, pruritus and allodynia in the affected dermatome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Does antiviral treatment reduce the risk of post herpetic neuralgia?

A

No!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is herpes zoster opthalmicus?

A

A potentially sight-threatening condition which is defined as herpes zoster involvement of the ophthalmic division of the fifth cranial nerve. Incidence of this complication range from 8-20%. Unilateral pain or hypesthesia in the affected eye, forehead, and top of the head may precede or follow the prodromal symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is ramsay hunt syndrome (herpes zoster oticus)?

A
  • Ipsilateral facial paralysis, ear pain and vesicles in auditory canal or on the auricle
  • Ipsilateral altered taste perception and tongue lesions, hearing abnormalities (decreased hearing, tinnitus, hyperacusis), and lacrimation occur in some patients; vestibular disturbances (vertigo) are also frequently reported. Note that the facial paralysis seen in Ramsay Hunt syndrome is often more severe than Bell’s palsy attributed to HSV, with increased rates of late neural denervation and a decreased probability of complete recovery.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe secondary bacterial infections that can result from herpes zoster?

A

Patients with localized herpes zoster are at risk for developing soft tissue infection with bacterial pathogens, particularly if they are immunocompromised. Common pathogens include Staphylococcus and Streptococcus.

Other neurologic complications
Encephalitis, Bell’s palsy
Disseminated herpes zoster

18
Q

Who is the SHINGRIX vaccine indicated for?

A

NEW Shingrix is now indicated for all adults 18 years of age or older who are considered at risk of herpes zoster due to immunodeficiency or immunosuppression caused by known disease or therapy.
Patients > 50 years old are still recommended to receive the vaccine regardless of the immune status

19
Q

What is the recommended dosing for Shingrix?

A

The series include 2 dose series of SHINGRIX®, second dose 2 to 6 months after the first dose. Nearly all Canadians eligible for HZ immunization will have had prior varicella exposure even if diagnosis cannot be recalled. Persons with active HZ should not be immunized with vaccine. Immunization may be considered at least one year following the last episode of herpes zoster for patients with prior history. Re-immunization with SHINGRIX® may be considered at least one year after ZOSTAVAX® II.

20
Q

Describe how long the shingles vaccine lasts for?

A
  • Maintained protection for 4 years
  • Waning of efficacy is slower than the live shingles vaccine ( 1 year live vaccine wanes)
  • Duration of protection is currently under investigation
21
Q

Describe immunogenicity of the Shingrix vaccine?

A

Immunity is the same across all age groups greater than 50 yo.

Demonstrated up to 9 years post-immunization.

22
Q

What are the most common AEs to the shingles vaccine?

A

Most common AEs: moderate to severe injection site reactions, fatigue, myalgia.

Long term data is not yet available as it is a new vaccine.

23
Q

What are contraindications to Shingrix?

A

Anaphylaxis

24
Q

What are precautions to the shingles vaccine?

A
  • pregnancy and breast feeding (no data)
25
Q

Describe using the shingles vaccine in immunocompromised individuals?

A

“Individuals who are immunocompromised, either due to underlying conditions or immunosuppressive agents, have an increased risk of developing HZ. They may be more likely to experience HZ recurrence, atypical and/or more severe disease and complications. RZV should be considered based on a case-by-case assessment of benefits vs risks. When indicated, it should be administered before initiating immunosuppressive treatment that might lead to immunodeficiency. It is recommended that RZV be administered at least 14 days before the treatment.”

26
Q

When should referral occur by a pharmacist presented with a patient who may or may not have shingles?

A
  • Presentation of rashes that does not follow dermatomes
  • Other atypical symptoms like rapidly enlarging, swollen, warm tender and painful lesions
  • Acute episodes in children and young adults (can not prescribe for kids <12 yrs)
  • Auricular or ocular involvement
  • Neurological changes such as confusion or delirium (to assess for differential diagnosis)
  • Extensive or rapidly progressing signs and symptoms of secondary bacterial infection
  • New blisters have formed or rash is not resolved after 7 to10 days
  • Immunocompromised due to medication or disease state such as HIV, malignancies, transplant recipients, azathiaprine, methotrexate, leflunomide, cyclosporine, monoclonal antibodies, TNF blockers, calcineurin inhibitors, systemic corticosteroids (>20mg per day for 14 days or more)
27
Q

What are the benefits of treatment for patients with shingles?

A
  • Treatment benefits patients > 50 years of age OR patients at risk of prolonged or severe symptoms
  • For younger and healthier patients, the antiviral treatment is not routinely recommended but can be provided if
    (a) patient requests treatment

(b) patient presents with severe acute pain associated with an acute episode of infection

(c) Low risk of side effects is anticipated

28
Q

What situations might treatment be initiated after 72 hours?

A

(a) immunocompromised where antiviral therapy should be initiated even if they present > 72 hours (REFERRAL IS ALWAYS REQUIRED).

(b) if ocular involvement, initiation of antiviral may be considered up to 7 days after onset (REFERRAL IS ALWAYS REQUIRED).

29
Q

Which antivirals are preferred over acyclovir?

A

Valayclovir and famciclovir - Less frequent dosing, ease of adherence and some evidence of superior efficacy in terms of resolving pain and accelerating healing

Evidence to support that antiviral therapy reduce the ocurrence of post-herpetic neuralgia

30
Q

Which antivirals are considered safe in pregnancy?

A

Acyclovir, and valacyclovir

31
Q
A
32
Q

Do these agents require adjustment in renal failure?

A

YES antivirals need adjustment

33
Q

Are topical antivirals effective for shingles?

A

NO!

34
Q

Describe the effectiveness of lidocaine?

A

Lidocaine 5% is effective in managing pain during acute episodes and post-herpetic neuralgia (however, patch formulations are studied in dosing of up to 3 patches at the same time for a maximum duration of 6 hours) 1

35
Q

WHen should capsaicin cream not and should be used in shingles?

A

Capsaicin cream should be avoided during an acute episode due to lack of data present on efficacy and associated discomfort such as burning and stinging. However, there is weak evidence of efficacy in managing post-herpetic neuralgia evaluated at a dosing regimen of 0.075% cream applied four times daily. 1

36
Q

What pain medications can be recommended for mild to moderate shingles pain?

A

Acetaminophen and NSAIDs can be recommended for mild to moderate shingles pain.
Other pain treatment options may include amitriptyline, gabapentin or pregabalin (referral might be required).

37
Q

When is shingles contagious?

A

Lesions crust in 7-10 days but during this time can be contagious. Patients with herpes zoster can transmit varicella-zoster virus (VZV) to individuals who have not had varicella and have not received the varicella vaccine. In general, shingles is less contagious than the chickenpox

38
Q

How long does pain persist after lesions heal?

A

Caution that pain may persist longer (days to weeks) and in some cases for few months after the lesion heals

39
Q

What are the most common side effects of oral antivirals?

A

Oral antivirals are well tolerated. Mild, transient headache and nausea are the most common side effects

40
Q
A